Awakn Life Sciences Corp C.AWKN

Alternate Symbol(s): AWKNF

Healthcare Psychedelics

Awakn Life Sciences Corp. is a Canada-based clinical-stage biotechnology company. The Company is developing therapeutics for substance use and mental health disorders, with a near-term focus on Alcohol Use Disorder (AUD). The Company's therapeutics are focused on the brain circuits that drive addiction, multiple receptors rather than the traditional single drug receptor targets. The Company operates through three segments: development, delivery and corporate. The development segment, which focuses on researching and developing psychedelic drugs and therapies, ketamine-assisted psychotherapy and methylenedioxy-methamphetamine (MDMA)-assisted psychotherapy to treat substance and behavioral addictions. The delivery segment, which includes a chain of medical psychedelic clinics across Europe and through licensing partners. The Company operates in Ireland and Canada. The Company’s development pipeline includes AWKN-001, AWKN-002 and MDMA.

CSE:AWKN - Post by User

Awakn Life Sciences Corp > Waiting

<< Previous

Bullboard Posts

Next >>

Comment by TheBridgeon Dec 17, 2024 10:40am

26 Views

Post# 36366168

RE:RE:Waiting

TheBridge wrote:
TheBridge wrote: Once this tax loss season is over we just might see this share price Awakin and start moving up. But as everyone knows these biotechs are a risky buiness and take a lot of time to determine whether there is success waiting at the end of the road. Good luck to all investors.

Looks like we didn't have to wait until the New Year to see the move. Pretty exciting times here!

Well it's not the New Year yet but we have a new name prior to the new year arriving. So we're Graft Polymer now, a UK entity and they obviously feel that we were worth taking out. Let's hope it works well for all of us.

<< Previous

Bullboard Posts

Next >>

Three business reasons companies need to recycle e-waste